Insulin Like Growth Factor I Market Report

China Insulin Like Growth Factor I Industry Market Research Report 2023-2029

  • POSTDATE：Oct 11, 2023
  • PAGES：166
  • REPORT CODE：GMM1844383
  • REPORT SUMMARY
  • TABLE OF CONTENTS

  • Insulin Like Growth Factor I is a group of peptides with growth-promoting effects. Its secreting cells are widely distributed in human liver, kidney, lung, heart, brain and intestinal tissues. Insulin Like Growth Factor I is an important growth factor in childhood because of its strong growth-promoting effect. Insulin Like Growth Factor I synthesized in various tissues mostly plays its role of promoting growth by autocrine or paracrine.

    At present, the industry competition of Insulin Like Growth Factor I is very fierce because of the fragmentation of the market. Despite the fragmentation of the market, Insulin Like Growth Factor I is still largely constrained by different regulatory requirements of the government. Utility owned industries are mainly driven by increasing financial incentives and regulatory support from governments around the world. At present, theInsulin Like Growth Factor I industry owned by utility companies is mainly affected by the COVID-19 pandemic.

    The major driver of global market for Insulin Like Growth Factor I is the increasing incidence of rare diseases such as Alzheimer's disease, breast cancer, Huntington's disease, and muscular dystrophy due to the increasing environmental pollution worldwide. In addition, technological advances are also driving the growth of the Insulin Like Growth Factor I market.

    This report elaborates on the current development of the Insulin Like Growth Factor I industry thoroughly based on the international market dynamics and China's market situation.

    For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.

    Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market. 

    Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.

    By Player:

    • Boehringer Ingelheim GmbH

    • MedImmune LLC

    • Genervon Biopharmaceuticals LLC

    By Type:

    • GM-6

    • CIGB-845

    • M-630

    • M-61027

    By Application:

    • Others

    • Breast Cancer

    • Alzheimer's Disease

    • Muscular Dystrophy

    • Huntington Disease

    By Research Region:

    • North China

    • Central China

    • South China

    • East China

    • Northeast China

    • Southwest China

    • Northwest China

  • TABLE OF CONTENT

    Chapter 1 China Insulin Like Growth Factor I Market Overview 2018-2029

    • 1.1 China Insulin Like Growth Factor I Industry Development Overview

    • 1.2 China Insulin Like Growth Factor I Industry Development History

    • 1.3 China Insulin Like Growth Factor I Industry Market Size (2018-2029)

    • 1.4 China Insulin Like Growth Factor I Market Analysis by Type from Production Side

      • 1.4.1 China Insulin Like Growth Factor I Production Volume, Production Value and Growth Rate of GM-6 (2018-2029)

      • 1.4.2 China Insulin Like Growth Factor I Production Volume, Production Value and Growth Rate of CIGB-845 (2018-2029)

      • 1.4.3 China Insulin Like Growth Factor I Production Volume, Production Value and Growth Rate of M-630 (2018-2029)

      • 1.4.4 China Insulin Like Growth Factor I Production Volume, Production Value and Growth Rate of M-61027 (2018-2029)

    • 1.5 China Insulin Like Growth Factor I Market Analysis by Application from Consumption End

      • 1.5.1 China Insulin Like Growth Factor I Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

      • 1.5.2 China Insulin Like Growth Factor I Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

      • 1.5.3 China Insulin Like Growth Factor I Sales Volume, Sales Value and Growth Rate of Alzheimer's Disease (2018-2029)

      • 1.5.4 China Insulin Like Growth Factor I Sales Volume, Sales Value and Growth Rate of Muscular Dystrophy (2018-2029)

      • 1.5.5 China Insulin Like Growth Factor I Sales Volume, Sales Value and Growth Rate of Huntington Disease (2018-2029)

    • 1.6 China Insulin Like Growth Factor I Market Analysis by Region

      • 1.6.1 North China Insulin Like Growth Factor I Market Size and Growth Rate from 2018-2029

      • 1.6.2 Central China Insulin Like Growth Factor I Market Size and Growth Rate from 2018-2029

      • 1.6.3 South China Insulin Like Growth Factor I Market Size and Growth Rate from 2018-2029

      • 1.6.4 East China Insulin Like Growth Factor I Market Size and Growth Rate from 2018-2029

      • 1.6.5 Northeast China Insulin Like Growth Factor I Market Size and Growth Rate from 2018-2029

      • 1.6.6 Southwest China Insulin Like Growth Factor I Market Size and Growth Rate from 2018-2029

      • 1.6.7 Northwest China Insulin Like Growth Factor I Market Size and Growth Rate from 2018-2029

    Chapter 2 China Insulin Like Growth Factor I Industry Development Environment

    • 2.1 Industry Development Environment Analysis

      • 2.1.1 Industry Technological Progress Analysis

      • 2.1.2 Industrial Organizational Innovation Analysis

      • 2.1.3 Changes in Social Habits

      • 2.1.4 Alterations in Government Policies

      • 2.1.5 Impact of Economic Globalization

    • 2.2 Domestic and Foreign Industry Competition Analysis

      • 2.2.1 Comparative Analysis on Insulin Like Growth Factor I Market Status and Competition at home and abroad in 2023

      • 2.2.2 China Insulin Like Growth Factor I Market Status and Competition Analysis in 2023

      • 2.2.3 China Insulin Like Growth Factor I Market Concentration Analysis in 2023

    • 2.3 Problems and Countermeasures in the development of China Insulin Like Growth Factor I Industry

      • 2.3.1 Industry Development Constraints

      • 2.3.2 Industry Development Considerations

      • 2.3.3 Suggestions on Industry Development Measures

      • 2.3.4 Development Strategies for SMEs

    • 2.4 Influence of COVID-19 Outbreak on Insulin Like Growth Factor I Industry Development

    Chapter 3 Insulin Like Growth Factor IIndustry Chain Analysis

    • 3.1 Insulin Like Growth Factor I Industry Chain

    • 3.2 Insulin Like Growth Factor I Upstream Industry Analysis

      • 3.2.1 Upstream Industry Development Status

      • 3.2.2 Upstream Industry Development Forecast

      • 3.2.3 Impact of Upstream Industry on the Insulin Like Growth Factor I Market

    • 3.3 Insulin Like Growth Factor I Downstream Industry Analysis

      • 3.3.1 Downstream Industry Development Status

      • 3.3.2 Downstream Industry Development Forecast

      • 3.3.3 Impact of Downstream Industry on the Insulin Like Growth Factor I Market

    Chapter 4 China Insulin Like Growth Factor I Market, by Type

    • 4.1 China Insulin Like Growth Factor I Market Trend, by Type

    • 4.2 Product Types of Major Suppliers

    • 4.3 Competitive Landscape of Major Types

    • 4.4 China Insulin Like Growth Factor I Total Production Volume and Growth Rate from Production Side

    • 4.5 China Insulin Like Growth Factor I Production Volume and Growth Rate, by Type

      • 4.5.1 China Insulin Like Growth Factor I Production Volume and Growth Rate of GM-6

      • 4.5.2 China Insulin Like Growth Factor I Production Volume and Growth Rate of CIGB-845

      • 4.5.3 China Insulin Like Growth Factor I Production Volume and Growth Rate of M-630

      • 4.5.4 China Insulin Like Growth Factor I Production Volume and Growth Rate of M-61027

    Chapter 5 China Insulin Like Growth Factor I Market, by Application

    • 5.1 Downstream Market Overview

    • 5.2 Competitive Landscape of Major Applications

    • 5.3 Market Potential Analysis, by Application

    • 5.4 China Insulin Like Growth Factor I Total Market Size and Growth Rate from Consumption End

    • 5.5 China Insulin Like Growth Factor I Market Size and Growth Rate, by Application

      • 5.5.1 China Insulin Like Growth Factor I Market Size and Growth Rate of Others

      • 5.5.2 China Insulin Like Growth Factor I Market Size and Growth Rate of Breast Cancer

      • 5.5.3 China Insulin Like Growth Factor I Market Size and Growth Rate of Alzheimer's Disease

      • 5.5.4 China Insulin Like Growth Factor I Market Size and Growth Rate of Muscular Dystrophy

      • 5.5.5 China Insulin Like Growth Factor I Market Size and Growth Rate of Huntington Disease

    Chapter 6 China Insulin Like Growth Factor I Market, by Region

    • 6.1 China Insulin Like Growth Factor I Production Volume and Production Value, by Region

    • 6.2 China Insulin Like Growth Factor I Sales Volume and Sales Value, by Region

    Chapter 7 North China Insulin Like Growth Factor I Market Analysis

    • 7.1 North China Insulin Like Growth Factor I Market, by Type

    • 7.2 North China Insulin Like Growth Factor I Market, by Application

    Chapter 8 Central China Insulin Like Growth Factor I Market Analysis

    • 8.1 Central China Insulin Like Growth Factor I Market, by Type

    • 8.2 Central China Insulin Like Growth Factor I Market, by Application

    Chapter 9 South China Insulin Like Growth Factor I Market Analysis

    • 9.1 South China Insulin Like Growth Factor I Market, by Type

    • 9.2 South China Insulin Like Growth Factor I Market, by Application

    Chapter 10 East China Insulin Like Growth Factor I Market Analysis

    • 10.1 East China Insulin Like Growth Factor I Market, by Type

    • 10.2 East China Insulin Like Growth Factor I Market, by Application

    Chapter 11 Northeast China Insulin Like Growth Factor I Market Analysis

    • 11.1 Northeast China Insulin Like Growth Factor I Market, by Type

    • 11.2 Northeast China Insulin Like Growth Factor I Market, by Application

    Chapter 12 Southwest China Insulin Like Growth Factor I Market Analysis

    • 12.1 Southwest China Insulin Like Growth Factor I Market, by Type

    • 12.2 Southwest China Insulin Like Growth Factor I Market, by Application

    Chapter 13 Northwest China Insulin Like Growth Factor I Market Analysis

    • 13.1 Northwest China Insulin Like Growth Factor I Market, by Type

    • 13.2 Northwest China Insulin Like Growth Factor I Market, by Application

    Chapter 14 Company Profiles

      • 14.1 Boehringer Ingelheim GmbH

        • 14.1.1 Boehringer Ingelheim GmbH Company Profile

        • 14.1.2 Boehringer Ingelheim GmbH Insulin Like Growth Factor I Market Performance

        • 14.1.3 Product&Service Introduction

      • 14.2 MedImmune LLC

        • 14.2.1 MedImmune LLC Company Profile

        • 14.2.2 MedImmune LLC Insulin Like Growth Factor I Market Performance

        • 14.2.3 Product&Service Introduction

      • 14.3 Genervon Biopharmaceuticals LLC

        • 14.3.1 Genervon Biopharmaceuticals LLC Company Profile

        • 14.3.2 Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Market Performance

        • 14.3.3 Product&Service Introduction

    Chapter 15 Research Conclusions and Investment Suggestions

    • 15.1 Insulin Like Growth Factor I Industry Research Conclusions

    • 15.2 Insulin Like Growth Factor I Industry Investment Suggestions

      • 15.2.1 Suggestions on Industry Development Strategy

      • 15.2.2 Suggestions on Industry Investment Direction

      • 15.2.3 Suggestions on Industry Investment Strategy


    List of Tables and Figures

    • Figure China Insulin Like Growth Factor I Industry Market Size (2018-2029)

    • Figure China Insulin Like Growth Factor I Production Volume, Production Value and Growth Rate of GM-6 (2018-2029)

    • Figure China Insulin Like Growth Factor I Production Volume, Production Value and Growth Rate of CIGB-845 (2018-2029)

    • Figure China Insulin Like Growth Factor I Production Volume, Production Value and Growth Rate of M-630 (2018-2029)

    • Figure China Insulin Like Growth Factor I Production Volume, Production Value and Growth Rate of M-61027 (2018-2029)

    • Figure China Insulin Like Growth Factor I Sales Volume, Sales Value and Growth Rate of Others (2018-2029)

    • Figure China Insulin Like Growth Factor I Sales Volume, Sales Value and Growth Rate of Breast Cancer (2018-2029)

    • Figure China Insulin Like Growth Factor I Sales Volume, Sales Value and Growth Rate of Alzheimer's Disease (2018-2029)

    • Figure China Insulin Like Growth Factor I Sales Volume, Sales Value and Growth Rate of Muscular Dystrophy (2018-2029)

    • Figure China Insulin Like Growth Factor I Sales Volume, Sales Value and Growth Rate of Huntington Disease (2018-2029)

    • Figure North China Insulin Like Growth Factor I Market Size and Growth Rate from 2018-2029

    • Figure Central China Insulin Like Growth Factor I Market Size and Growth Rate from 2018-2029

    • Figure South China Insulin Like Growth Factor I Market Size and Growth Rate from 2018-2029

    • Figure East China Insulin Like Growth Factor I Market Size and Growth Rate from 2018-2029

    • Figure Northeast China Insulin Like Growth Factor I Market Size and Growth Rate from 2018-2029

    • Figure Southwest China Insulin Like Growth Factor I Market Size and Growth Rate from 2018-2029

    • Figure Northwest China Insulin Like Growth Factor I Market Size and Growth Rate from 2018-2029

    • Figure Insulin Like Growth Factor I Industry Chain

    • Table Product Types of Major Suppliers in 2023

    • Figure China Insulin Like Growth Factor I Market Share by Type in 2018

    • Figure China Insulin Like Growth Factor I Market Share by Type in 2023

    • Figure China Insulin Like Growth Factor I Total Production Volume and Growth Rate from Production Side (2018-2023)

    • Figure China Insulin Like Growth Factor I Production Volume and Growth Rate of GM-6 (2018-2023)

    • Figure China Insulin Like Growth Factor I Production Volume and Growth Rate of CIGB-845 (2018-2023)

    • Figure China Insulin Like Growth Factor I Production Volume and Growth Rate of M-630 (2018-2023)

    • Figure China Insulin Like Growth Factor I Production Volume and Growth Rate of M-61027 (2018-2023)

    • Figure China Insulin Like Growth Factor I Market Share by Application in 2018

    • Figure China Insulin Like Growth Factor I Market Share by Application in 2023

    • Figure China Insulin Like Growth Factor I Total Market Size and Growth Rate from Consumption End

    • Figure China Insulin Like Growth Factor I Market Size and Growth Rate of Others (2018-2023)

    • Figure China Insulin Like Growth Factor I Market Size and Growth Rate of Breast Cancer (2018-2023)

    • Figure China Insulin Like Growth Factor I Market Size and Growth Rate of Alzheimer's Disease (2018-2023)

    • Figure China Insulin Like Growth Factor I Market Size and Growth Rate of Muscular Dystrophy (2018-2023)

    • Figure China Insulin Like Growth Factor I Market Size and Growth Rate of Huntington Disease (2018-2023)

    • Table China Insulin Like Growth Factor I Production Volume by Region (2018-2023)

    • Table China Insulin Like Growth Factor I Production Volume Share by Region (2018-2023)

    • Figure China Insulin Like Growth Factor I Production Volume Share by Region (2018-2023)

    • Table China Insulin Like Growth Factor I Production Value by Region (2018-2023)

    • Table China Insulin Like Growth Factor I Production Value Share by Region (2018-2023)

    • Figure China Insulin Like Growth Factor I Production Value Share by Region (2018-2023)

    • Table China Insulin Like Growth Factor I Sales Volume by Region (2018-2023)

    • Table China Insulin Like Growth Factor I Sales Volume Share by Region (2018-2023)

    • Figure China Insulin Like Growth Factor I Sales Volume Share by Region (2018-2023)

    • Table China Insulin Like Growth Factor I Sales Value by Region (2018-2023)

    • Table China Insulin Like Growth Factor I Sales Value Share by Region (2018-2023)

    • Figure China Insulin Like Growth Factor I Sales Value Share by Region (2018-2023)

    • Table North China Insulin Like Growth Factor I Production Volume by Type (2018-2023)

    • Table North China Insulin Like Growth Factor I Production Volume Share by Type (2018-2023)

    • Figure North China Insulin Like Growth Factor I Production Volume Share by Type (2018-2023)

    • Table North China Insulin Like Growth Factor I Sales Volume by Application (2018-2023)

    • Table North China Insulin Like Growth Factor I Sales Volume Share by Application (2018-2023)

    • Figure North China Insulin Like Growth Factor I Sales Volume Share by Application (2018-2023)

    • Table Central China Insulin Like Growth Factor I Production Volume by Type (2018-2023)

    • Table Central China Insulin Like Growth Factor I Production Volume Share by Type (2018-2023)

    • Figure Central China Insulin Like Growth Factor I Production Volume Share by Type (2018-2023)

    • Table Central China Insulin Like Growth Factor I Sales Volume by Application (2018-2023)

    • Table Central China Insulin Like Growth Factor I Sales Volume Share by Application (2018-2023)

    • Figure Central China Insulin Like Growth Factor I Sales Volume Share by Application (2018-2023)

    • Table South China Insulin Like Growth Factor I Production Volume by Type (2018-2023)

    • Table South China Insulin Like Growth Factor I Production Volume Share by Type (2018-2023)

    • Figure South China Insulin Like Growth Factor I Production Volume Share by Type (2018-2023)

    • Table South China Insulin Like Growth Factor I Sales Volume by Application (2018-2023)

    • Table South China Insulin Like Growth Factor I Sales Volume Share by Application (2018-2023)

    • Figure South China Insulin Like Growth Factor I Sales Volume Share by Application (2018-2023)

    • Table East China Insulin Like Growth Factor I Production Volume by Type (2018-2023)

    • Table East China Insulin Like Growth Factor I Production Volume Share by Type (2018-2023)

    • Figure East China Insulin Like Growth Factor I Production Volume Share by Type (2018-2023)

    • Table East China Insulin Like Growth Factor I Sales Volume by Application (2018-2023)

    • Table East China Insulin Like Growth Factor I Sales Volume Share by Application (2018-2023)

    • Figure East China Insulin Like Growth Factor I Sales Volume Share by Application (2018-2023)

    • Table Northeast China Insulin Like Growth Factor I Production Volume by Type (2018-2023)

    • Table Northeast China Insulin Like Growth Factor I Production Volume Share by Type (2018-2023)

    • Figure Northeast China Insulin Like Growth Factor I Production Volume Share by Type (2018-2023)

    • Table Northeast China Insulin Like Growth Factor I Sales Volume by Application (2018-2023)

    • Table Northeast China Insulin Like Growth Factor I Sales Volume Share by Application (2018-2023)

    • Figure Northeast China Insulin Like Growth Factor I Sales Volume Share by Application (2018-2023)

    • Table Southwest China Insulin Like Growth Factor I Production Volume by Type (2018-2023)

    • Table Southwest China Insulin Like Growth Factor I Production Volume Share by Type (2018-2023)

    • Figure Southwest China Insulin Like Growth Factor I Production Volume Share by Type (2018-2023)

    • Table Southwest China Insulin Like Growth Factor I Sales Volume by Application (2018-2023)

    • Table Southwest China Insulin Like Growth Factor I Sales Volume Share by Application (2018-2023)

    • Figure Southwest China Insulin Like Growth Factor I Sales Volume Share by Application (2018-2023)

    • Table Northwest China Insulin Like Growth Factor I Production Volume by Type (2018-2023)

    • Table Northwest China Insulin Like Growth Factor I Production Volume Share by Type (2018-2023)

    • Figure Northwest China Insulin Like Growth Factor I Production Volume Share by Type (2018-2023)

    • Table Northwest China Insulin Like Growth Factor I Sales Volume by Application (2018-2023)

    • Table Northwest China Insulin Like Growth Factor I Sales Volume Share by Application (2018-2023)

    • Figure Northwest China Insulin Like Growth Factor I Sales Volume Share by Application (2018-2023)

    • Table Boehringer Ingelheim GmbH Company Profile

    • Table Boehringer Ingelheim GmbH Insulin Like Growth Factor I Revenue, Price and Gross (2018-2023)

    • Table MedImmune LLC Company Profile

    • Table MedImmune LLC Insulin Like Growth Factor I Revenue, Price and Gross (2018-2023)

    • Table Genervon Biopharmaceuticals LLC Company Profile

    • Table Genervon Biopharmaceuticals LLC Insulin Like Growth Factor I Revenue, Price and Gross (2018-2023)


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.

CONTACT US